153 related articles for article (PubMed ID: 21944272)
1. Intrauterine growth restriction may not suppress bone formation at term, as indicated by circulating concentrations of undercarboxylated osteocalcin and Dickkopf-1.
Briana DD; Gourgiotis D; Georgiadis A; Boutsikou M; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
Metabolism; 2012 Mar; 61(3):335-40. PubMed ID: 21944272
[TBL] [Abstract][Full Text] [Related]
2. Perinatal bone turnover in term pregnancies: the influence of intrauterine growth restriction.
Briana DD; Gourgiotis D; Boutsikou M; Baka S; Hassiakos D; Vraila VM; Creatsas G; Malamitsi-Puchner A
Bone; 2008 Feb; 42(2):307-13. PubMed ID: 18024242
[TBL] [Abstract][Full Text] [Related]
3. Associations of novel adipocytokines with bone biomarkers in intra uterine growth-restricted fetuses/neonates at term.
Briana DD; Boutsikou M; Boutsikou T; Malamitsi-Puchner A
J Matern Fetal Neonatal Med; 2014 Jul; 27(10):984-8. PubMed ID: 24106768
[TBL] [Abstract][Full Text] [Related]
4. Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies.
Briana DD; Boutsikou M; Baka S; Gourgiotis D; Marmarinos A; Liosi S; Hassiakos D; Malamitsi-Puchner A
Metabolism; 2011 Apr; 60(4):486-90. PubMed ID: 20488498
[TBL] [Abstract][Full Text] [Related]
5. Soluble fas antigen and soluble fas ligand in intrauterine growth restriction.
Briana DD; Baka S; Boutsikou M; Liosi S; Vraila VM; Gourgiotis D; Hassiakos D; Malamitsi-Puchner A
Neonatology; 2010; 97(1):31-5. PubMed ID: 19590243
[TBL] [Abstract][Full Text] [Related]
6. Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction.
Briana DD; Boutsikou M; Baka S; Hassiakos D; Gourgiotis D; Malamitsi-Puchner A
Neonatology; 2009; 96(2):132-6. PubMed ID: 19365143
[TBL] [Abstract][Full Text] [Related]
7. Perinatal collagen turnover markers in intrauterine growth restriction.
Gourgiotis D; Briana DD; Georgiadis A; Boutsikou M; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1719-22. PubMed ID: 22339296
[TBL] [Abstract][Full Text] [Related]
8. Perinatal changes of plasma resistin concentrations in pregnancies with normal and restricted fetal growth.
Briana DD; Boutsikou M; Baka S; Gourgiotis D; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
Neonatology; 2008; 93(3):153-7. PubMed ID: 17878741
[TBL] [Abstract][Full Text] [Related]
9. Serum cystatin C in pregnancies with normal and restricted fetal growth.
Malamitsi-Puchner A; Briana DD; Kontara L; Boutsikou M; Baka S; Hassiakos D; Marmarinos A; Gourgiotis D
Reprod Sci; 2007 Jan; 14(1):37-42. PubMed ID: 17636214
[TBL] [Abstract][Full Text] [Related]
10. Serum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth.
Briana DD; Boutsikou M; Gourgiotis D; Boutsikou T; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
J Matern Fetal Neonatal Med; 2008 Nov; 21(11):826-30. PubMed ID: 19031279
[TBL] [Abstract][Full Text] [Related]
11. Serum Beta-2-microglobulin levels in intrauterine growth-restricted and normal pregnancies.
Kontara L; Briana DD; Baka S; Boutsikou M; Marmarinos A; Gourgiotis D; Malamitsi-Puchner A
Fetal Diagn Ther; 2008; 24(3):220-4. PubMed ID: 18753761
[TBL] [Abstract][Full Text] [Related]
12. Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates.
Boutsikou T; Malamitsi-Puchner A; Economou E; Boutsikou M; Puchner KP; Hassiakos D
Early Hum Dev; 2006 Apr; 82(4):235-9. PubMed ID: 16337100
[TBL] [Abstract][Full Text] [Related]
13. The effect of intrauterine growth restriction on circulating surfactant protein D concentrations in the perinatal period.
Briana DD; Gourgiotis D; Baka S; Boutsikou M; Vraila VM; Boutsikou T; Hassiakos D; Malamitsi-Puchner A
Reprod Sci; 2010 Jul; 17(7):653-8. PubMed ID: 20360592
[TBL] [Abstract][Full Text] [Related]
14. Intrauterine growth restriction and circulating neurotrophin levels at term.
Malamitsi-Puchner A; Nikolaou KE; Economou E; Boutsikou M; Boutsikou T; Kyriakakou M; Puchner KP; Hassiakos D
Early Hum Dev; 2007 Jul; 83(7):465-9. PubMed ID: 17071024
[TBL] [Abstract][Full Text] [Related]
15. Circulating apelin concentrations in mother/infant pairs at term.
Malamitsi-Puchner A; Gourgiotis D; Boutsikou M; Baka S; Hassiakos D; Briana DD
Acta Paediatr; 2007 Dec; 96(12):1751-4. PubMed ID: 18001333
[TBL] [Abstract][Full Text] [Related]
16. Effect of intrauterine growth pattern on serum visfatin concentrations in full-term infants at birth and at 6 months of life.
El Shemi MS; Mohamed MH; AbdelRahman AO; Abdel Al H; Ramadan NM
J Neonatal Perinatal Med; 2016; 9(1):73-82. PubMed ID: 27002258
[TBL] [Abstract][Full Text] [Related]
17. Perinatal changes of circulating N-terminal pro B-type natriuretic peptide (NT-proBNP) in normal and intrauterine-growth-restricted pregnancies.
Iacovidou N; Briana DD; Boutsikou M; Gourgiotis D; Baka S; Vraila VM; Hassiakos D; Malamitsi-Puchner A
Hypertens Pregnancy; 2007; 26(4):463-71. PubMed ID: 18066964
[TBL] [Abstract][Full Text] [Related]
18. Perinatal plasma monocyte chemotactic protein-1 concentrations in intrauterine growth restriction.
Briana DD; Boutsikou M; Baka S; Papadopoulos G; Gourgiotis D; Puchner KP; Hassiakos D; Malamitsi-Puchner A
Mediators Inflamm; 2007; 2007():65032. PubMed ID: 18274642
[TBL] [Abstract][Full Text] [Related]
19. Plasma copeptin may not be a sensitive marker of perinatal stress in healthy full-term growth-restricted fetuses.
Briana DD; Boutsikou M; Boutsikou T; Dodopoulos T; Gourgiotis D; Malamitsi-Puchner A
J Matern Fetal Neonatal Med; 2017 Mar; 30(6):705-709. PubMed ID: 27125294
[TBL] [Abstract][Full Text] [Related]
20. The role of the anti-angiogenic factor endostatin in intrauterine growth restriction.
Malamitsi-Puchner A; Boutsikou T; Economou E; Makrakis E; Iliodromiti Z; Kouskouni E; Hassiakos D
J Soc Gynecol Investig; 2005 Apr; 12(3):195-7. PubMed ID: 15784505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
